SeaStar Medical Holding Corp (ICU)
0.45
-0.02
(-4.92%)
USD |
NASDAQ |
May 08, 10:50
SeaStar Medical Cash from Operations (TTM): -10.28M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.28M |
| September 30, 2023 | -11.10M |
| June 30, 2023 | -10.68M |
| March 31, 2023 | -9.501M |
| Date | Value |
|---|---|
| December 31, 2022 | -7.794M |
| September 30, 2022 | -3.451M |
| June 30, 2022 | -4.237M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-11.10M
Minimum
Sep 2023
-3.451M
Maximum
Sep 2022
-8.150M
Average
-9.501M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| Nuwellis Inc | -17.94M |
| Ardelyx Inc | -80.64M |
| Adverum Biotechnologies Inc | -90.90M |
| Aquestive Therapeutics Inc | -6.38M |
| Vir Biotechnology Inc | -- |